Role of Extrarenal 1-Alpha-Hydroxylase in Patients With End Stage Renal Disease
NCT00677534
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
7
Enrollment
OTHER
Sponsor class
Conditions
End-Stage Renal Disease
Interventions
DRUG:
Cholecalciferol
Sponsor
University of Kansas